# Intracervical Vasopressin

> **NCT07102615** · PHASE4 · RECRUITING · sponsor: **Prisma Health-Upstate** · enrollment: 50 (estimated)

## Conditions studied

- Retained Products of Conception

## Interventions

- **DRUG:** Intracervical injection of Vasopressin
- **DRUG:** Intracervical Injection of saline

## Key facts

- **NCT ID:** NCT07102615
- **Lead sponsor:** Prisma Health-Upstate
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-30
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07102615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07102615, "Intracervical Vasopressin". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07102615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*